MYCOSTATIN Drug Patent Profile
✉ Email this page to a colleague
When do Mycostatin patents expire, and what generic alternatives are available?
Mycostatin is a drug marketed by Delcor Asset Corp and is included in seven NDAs.
The generic ingredient in MYCOSTATIN is nystatin. There are eight drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nystatin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mycostatin
A generic version of MYCOSTATIN was approved as nystatin by FOUGERA PHARMS on September 23rd, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MYCOSTATIN?
- What are the global sales for MYCOSTATIN?
- What is Average Wholesale Price for MYCOSTATIN?
Summary for MYCOSTATIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 21 |
Clinical Trials: | 6 |
Patent Applications: | 86 |
DailyMed Link: | MYCOSTATIN at DailyMed |
Recent Clinical Trials for MYCOSTATIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Rochester | Phase 1 |
National Cancer Institute (NCI) | Phase 2 |
M.D. Anderson Cancer Center | Phase 2 |
US Patents and Regulatory Information for MYCOSTATIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Delcor Asset Corp | MYCOSTATIN | nystatin | CREAM;TOPICAL | 060575-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Delcor Asset Corp | MYCOSTATIN | nystatin | TABLET;VAGINAL | 060577-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Delcor Asset Corp | MYCOSTATIN | nystatin | POWDER;TOPICAL | 060578-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |